JOUNCE THERAPEUTICS INC's ticker is JNCE and the CUSIP is 481116101. A total of 126 filers reported holding JOUNCE THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $4,348 | +240.5% | 2,350 | +88.0% | 0.00% | – |
| Q4 2022 | $1,277 | – | 1,250 | +1150.0% | 0.00% | – |
| Q3 2022 | $0 | – | 100 | 0.0% | 0.00% | – |
| Q2 2022 | $0 | -100.0% | 100 | -24.2% | 0.00% | – |
| Q1 2022 | $1,000 | 0.0% | 132 | 0.0% | 0.00% | – |
| Q4 2021 | $1,000 | 0.0% | 132 | +32.0% | 0.00% | – |
| Q3 2021 | $1,000 | 0.0% | 100 | 0.0% | 0.00% | – |
| Q2 2021 | $1,000 | 0.0% | 100 | 0.0% | 0.00% | – |
| Q1 2021 | $1,000 | -98.6% | 100 | -99.0% | 0.00% | – |
| Q4 2020 | $69,000 | +40.8% | 9,899 | +42.3% | 0.00% | – |
| Q3 2020 | $49,000 | +4.3% | 6,954 | +1.4% | 0.00% | – |
| Q2 2020 | $47,000 | +104.3% | 6,858 | +46.5% | 0.00% | – |
| Q1 2020 | $23,000 | – | 4,680 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP II, LLC | 9,200,349 | $64,402,000 | 44.86% |
| TRV GP III, LLC | 3,048,780 | $21,342,000 | 1.83% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 406,665 | $2,847,000 | 1.65% |
| Sofinnova Investments, Inc. | 925,280 | $6,477,000 | 0.39% |
| Omega Fund Management, LLC | 334,965 | $2,345,000 | 0.35% |
| Yorktown Management & Research Co Inc | 49,200 | $344,000 | 0.31% |
| Woodline Partners LP | 940,902 | $6,586,000 | 0.18% |
| HUSSMAN STRATEGIC ADVISORS, INC. | 51,000 | $357,000 | 0.09% |
| HORIZON FINANCIAL SERVICES, LLC | 12,005 | $84,000 | 0.08% |
| Gyon Technologies Capital Management, LP | 26,893 | $188,000 | 0.06% |